Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (201-210 of 403) with videos related to

Pageof 41
Sort By:
Clinical and Vaccine Immunology : CVI|December 3, 2010
Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPJay Lucidarme, Lynne S Newbold, Jamie Findlow, et al.
Sexually Transmitted Diseases|February 15, 2011
Prevalence of human papillomavirus antibodies in males and females in EnglandSarika Desai, Ruth Chapman, Mark Jit, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Vaccine|February 21, 2025
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigensJulia L McKechnie, Elizabeth Kepl, Jennifer Louth, et al.
Infection and Immunity|June 18, 2002
Neisseria lactamica protects against experimental meningococcal infectionKerry J Oliver, Karen M Reddin, Philippa Bracegirdle, et al.
The Lancet. Child & Adolescent Health|December 9, 2021
Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling studyHelen Campbell, Nick Andrews, Sydel R Parikh, et al.
Vaccine|June 15, 2021
Post-vaccination HPV seroprevalence among female sexual health clinic attenders in EnglandDavid Mesher, Sara L Thomas, Ezra Linley, et al.
Emerging Infectious Diseases|August 24, 2019
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016Godwin Oligbu, Sarah Collins, Abdelmajid Djennad, et al.
The Lancet. Infectious Diseases|February 4, 2018
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort studyShamez N Ladhani, Sarah Collins, Abdelmajid Djennad, et al.
The New England Journal of Medicine|January 24, 2020
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandShamez N Ladhani, Nick Andrews, Sydel R Parikh, et al.
Pageof 41

Showing results (201-210 of 403) with videos related to

Sort By:
Pageof 41
Clinical and Vaccine Immunology : CVI|December 3, 2010
Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPJay Lucidarme, Lynne S Newbold, Jamie Findlow, et al.
Sexually Transmitted Diseases|February 15, 2011
Prevalence of human papillomavirus antibodies in males and females in EnglandSarika Desai, Ruth Chapman, Mark Jit, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Vaccine|February 21, 2025
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigensJulia L McKechnie, Elizabeth Kepl, Jennifer Louth, et al.
Infection and Immunity|June 18, 2002
Neisseria lactamica protects against experimental meningococcal infectionKerry J Oliver, Karen M Reddin, Philippa Bracegirdle, et al.
The Lancet. Child & Adolescent Health|December 9, 2021
Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling studyHelen Campbell, Nick Andrews, Sydel R Parikh, et al.
Vaccine|June 15, 2021
Post-vaccination HPV seroprevalence among female sexual health clinic attenders in EnglandDavid Mesher, Sara L Thomas, Ezra Linley, et al.
Emerging Infectious Diseases|August 24, 2019
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016Godwin Oligbu, Sarah Collins, Abdelmajid Djennad, et al.
The Lancet. Infectious Diseases|February 4, 2018
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort studyShamez N Ladhani, Sarah Collins, Abdelmajid Djennad, et al.
The New England Journal of Medicine|January 24, 2020
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandShamez N Ladhani, Nick Andrews, Sydel R Parikh, et al.
Pageof 41